Change search criteria ↓

Search results

19 projects found matching your search criteria:

  1. 1. Multiparameter analysis of co-inhibitory and co-stimulatory immune checkpoints and their role in the induction of immuno…

    Principal investigator: dr Dorota Suszczyk

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 22, Panel: NZ6

  2. 2. Structural and functional analysis of immune checkpoints

    Principal investigator: prof. Grzegorz Dubin

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

    Call: OPUS 13, Panel: NZ1

  3. 3. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 22, Panel: NZ7

  4. 4. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ6

  5. 5. The immune checkpoints in non-small cell lung cancer - research on genetic and epigenetic mechanism regulating mRNA and …

    Principal investigator: dr hab. Monika Jasek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 17, Panel: NZ5

  6. 6. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

    Call: PRELUDIUM 24, Panel: NZ7

  7. 7. Novel insights into inhibition of PD-L1/PD-1 immune checkpoint – discovery and optimization of covalent PD-L1 inhibitors…

    Principal investigator: dr Radosław Dariusz Kitel

    Uniwersytet Jagielloński

    Call: SONATA 20, Panel: ST5

  8. 8. Single cell multi-omics in defining how specific oncogenic alterations shape the immune microenvironment and responses t…

    Principal investigator: prof. Bożena Kamińska-Kaczmarek

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 20, Panel: NZ4

  9. 9. The role of arginase-1 in antitumor efficacy of cancer immunotherapy using checkpoint inhibitors

    Principal investigator: prof. Dominika Anna Nowis

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 12, Panel: NZ6

  10. 10. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  11. 11. Role of microparticles derived from platelets and cancer cells in colorectal cancer progression – how to stop them or tu…

    Principal investigator: prof. Maria Anna Kowalska

    Instytut Biologii Medycznej PAN

    Call: OPUS 24, Panel: NZ5

  12. 12. Use of comparative oncology approach to dissect the PD-1 intrinsic signalling in osteosarcoma. Can dog be the key for ne…

    Principal investigator: Katarzyna Joanna Dziubek

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: PRELUDIUM 21, Panel: NZ1

  13. 13. Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 pro…

    Principal investigator: dr Łukasz Dariusz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA BIS 11, Panel: NZ7

  14. 14. The SAR analysis and synthesis of complex, small molecule PD-1/PD-L1 interaction antagonists

    Principal investigator: Magdalena Maria Żarnik

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 20, Panel: ST4

  15. 15. The clinical significance of immunosuppression in ovarian cancer microenvironments

    Principal investigator: dr Anna Maria Pawłowska-Łachut

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 20, Panel: NZ6

  16. 16. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 19, Panel: NZ7

  17. 17. Development of a three-dimensional in vitro model for studying the mechanisms of immunostimulatory activity of PD-1/PD-L…

    Principal investigator: Justyna Natalia Kocik-Król

    Uniwersytet Jagielloński, Wydział Chemii

    Call: PRELUDIUM 18, Panel: NZ5

  18. 18. Inhibitors of BTLA-HVEM complex formation as potential targets for cancer immunotheraphy

    Principal investigator: dr Marta Marcelina Spodzieja

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 13, Panel: ST5

  19. 19. Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 12, Panel: NZ6

Graphic design and implementation: Jakub Piotrowski